Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10828340 Microbiota restoration therapy (MRT) compositions and methods of manufacture

Patent 10828340 was granted and assigned to Rebiotix on November, 2020 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Rebiotix

Current Assignee

Rebiotix

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

10828340

Date of Patent

November 10, 2020

Patent Application Number

16009157

Date Filed

June 14, 2018

Patent Citations Received

‌

US Patent 12102655 Bacteriotherapy for clostridium difficile colitis

‌

US Patent 11986500 Bacteriotherapy for clostridium difficile colitis

‌

US Patent 12083150 Microbiota restoration therapy (MRT), composition and methods of manufacture

‌

US Patent 11554143 Microbiota restoration therapy (MRT), compositions and methods of manufacture

‌

US Patent 11642381 Microbiota restoration therapy (MRT) compositions and methods of manufacture

‌

US Patent 11654164 Microbiota restoration therapy (MRT) compositions and methods of manufacture

‌

US Patent 11446337 Bacteriotherapy for clostridium difficile colitis

‌

US Patent 11944654 Bacteriotherapy for clostridium difficile colitis

Patent Primary Examiner

‌

Irina S. Zemel

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10828340 Microbiota restoration therapy (MRT) compositions and methods of manufacture

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API